Date Submitted: Mon, 02 Apr 2018 21:29:35 GMT

LAW 1145 v00 : Mergers and Acquisitions in Practice: Advising the Board of Directors

Last edit: Fri, 02 Feb 2018 20:12:11 GMT

Druthers submitted by: abs55
JD Adjunct
UserID Name Email
abs55 Stebbins, Ann Beth
sfa22 Arcano, Stephen
LAW 1145 v00: Mergers and Acquisitions in Practice: Advising the Board of Directors
Mergers and Acquisitions in Practice: Advising the Board of Directors
F 4:00-7:30p; Sa 10:00a-6:00p; Su 9:00a-12:30p
3/22/19, 3/23/19, 3/24/19
Special Requirement




ATTENDANCE IS MANDATORY AT ALL CLASS SESSIONS. All enrolled and waitlisted students must be in attendance at the start of the first class session in order to be eligible for a seat in the class and must attend each class session in its entirety. This course is offered on a mandatory pass/fail basis and will not count toward the 7 credit pass/fail limit for J.D. students.

Note: This course is offered on a mandatory pass/fail basis and will not count toward the 7 credit pass/fail limit for J.D. students.

A student will be permitted to drop a course that meets for the first time after the add/drop period, without a transcript notation, if a student submits a written request to the Office of the Registrar prior to the start of the second class meeting. Withdrawals are permitted up until the last class for this specific course.

Note: Students should be prepared to dedicate a significant amount of time to this class over the course of the weekend outside of the scheduled class hours.

Would you like to offer the Pass/Fail grading option?

Does this course qualify as a "simulation course"?

Is this course available to distance students?

Is this a mandatory Pass-Fail course?


Personal Information


Ann Beth Stebbins is a corporate partner in Skadden’s New York office who concentrates primarily on mergers and acquisitions. Professor Stebbins spent eight years in the firm’s London office and has been involved in a variety of cross-border transactions representing acquirers, targets and financial advisors.Professor Stebbins’ representative transactions include:• Agere Systems, Inc. in its $4 billion merger with LSI Logic Corporation;• Alcatel in its $12 billion merger with Lucent Technologies Inc.;• Amylin Pharmaceuticals, Inc. in its $7 billion acquisition by Bristol-Myers Squibb Company;• Apax Partners LLP in:

the sale of a majority stake in Advantage Sales & Marketing LLC to affiliates of private equity firm Leonard Green & Partners, L.P. and funds advised by CVC Capital Partners Limited;

its acquisition of Advantage Sales & Marketing from J.W. Childs Equity Partners and ML Global Private Equity Fund;

its acquisition of Tivit, a leading technology service provider in Brazil; and

the formation of Advantage-Waypoint, LLC, a consortium of food service brokers;

• Bally Technologies, Inc., a manufacturer and distributor of gaming devices, in its $100 million acquisition of Dragonplay Ltd. (Israel), a developer of online games; and its $5.1 billion acquisition by Scientific Games Corporation, a supplier of instantwin lottery tickets and a manufacturer of lottery terminals;• Basell AF in its $19 billion acquisition of Lyondell Chemical Company;

• Citibank Banking Corporation in its sale of Citi Technology Services, Ltd. to Wipro Limited;

• Colfax Corporation, a manufacturer of fluid handling products, in its $947 million acquisition of Victor Technologies Group Inc., a manufacturer of industrial equipment, from Irving Place Capital, a private equity firm;

• Daimler Chrysler AG in its sale of a majority interest in Chrysler Corporation to a subsidiary of Cerberus Capital Management L.P.; • Empresas Polar S.A. in connection with the formation of a joint venture with PepsiCo, Inc. and Grupo Embotelladoras Unidas, S.A.B. de C.V. to manufacture and distribute beverages in Mexico;

• Endo Pharmaceuticals Holdings Inc. in its $370 million acquisition of Indevus Pharmaceuticals, Inc. and its $168 million acquisition of Penwest Pharmaceuticals Co.;

• FiberMark, Inc., a portfolio company of Silver Point Capital, in the sale of its German and North American subsidiaries;

• Gold Fields Limited in its defense against a hostile $7 billion bid from Harmony Gold Mining Company Limited;• the special committee of the board of directors of Golden Telecom, Inc. in the sale of Golden Telecom to Vimpel-Communications;• Goldman Sachs, Morgan Stanley and Rothschild as financial advisors to Aventis SA in Sanofi-Synthélabo’s $68 billion acquisition of Aventis;• Gucci Group N.V.:

in its successful defense against a hostile takeover attempt by LVMH Moët Hennessy Louis Vuitton S.A.;

and its independent directors in connection with Pinault-Printemps-Redoute’s acquisition of the publicly held shares of Gucci; and

in numerous acquisitions of European luxury goods companies, including Sanofi Beauté (which includes the Yves Saint Laurent clothing and perfume businesses), Balenciaga S.A., Stella McCartney Ltd., Alexander McQueen Ltd. and Bedat S.A.;

• J. C. Penney Company, Inc. in its acquisition of the Liz Claiborne and Monet trademarks from Liz Claiborne, Inc.;• Pharmaceutical Product Development, Inc. in its $3.9 billion sale to The Carlyle Group and Hellman & Friedman;• SeaCube Containers, Ltd. in its $1.7 billion acquisition by Ontario Teachers’ Pension Plan;• the independent members of the board of directors of Time Warner Cable Inc. in its $45 billion acquisition by Comcast Corporation;• Valeant Pharmaceuticals International in the sale of its European subsidiaries to Meda A.B. and in its collaboration agreement with GlaxoSmithKline for the development of Retigabine;• Westfield Group in its $5 billion acquisition, together with Simon Property Group and the Rouse Company, of the assets of Rodamco North America, N.V.; and• WildBlue Communications, Inc. in its acquisition by Viasat Inc.Professor Stebbins lectures and participates in seminars on topics related to her practice. In 2012, she was recognized as one of five “Outstanding Women Leaders” by Georgetown University Law Center. She also has been named as a “Woman Dealmaker of the Year” by The M&A Advisor.

Key: 554